Work

Supplemental Methods from Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Methods

DOI: 10.1158/1078-0432.22467855

Authors: Alfredo Perales-Puchalt, Nikolaos Svoronos, Melanie R. Rutkowski, Michael J. Allegrezza, Amelia J. Tesone, Kyle K. Payne, Jayamanna Wickramasinghe, Jenny M. Nguyen, Shane W. O'Brien, Kiranmai Gumireddy, Qihong Huang, Mark G. Cadungog, Denise C. Connolly, Julia Tchou, Tyler J. Curiel, Jose R. Conejo-Garcia

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361969840

Cites: 3

Cited by:

Related to: 10